Canos GTM brain

category

market profile

• text: Dog cancer testing combines a pet owner's willingness to pay with veterinary collection and interpretation.
• text: Canine molecular cancer screens compete with established veterinary diagnostic laboratory offerings.

personas

• title: Owner of an aging or cancer-treated dog
  pains:

  • Wants more information about cancer risk and recurrence without repeated invasive procedures.
  • Needs help understanding what a blood test can and cannot tell them.
• title: Veterinarian or veterinary oncologist
  pains:

  • Needs actionable test context and a practical blood-draw workflow.
  • Must explain uncertain screening results and follow-up to owners.

icp

• text: Dog-owning households seeking preventive care or monitoring after a cancer diagnosis, initially in San Francisco and New York City.
• text: Mobile veterinarians and clinics able to draw blood and review reports with the Canos team.

message pillars

• text: Bring precision cancer care to dogs through blood genomics.
• text: Offer a baseline encompassing genetics, aging and cancer signals.
• text: Support monitoring across the cancer journey.

objections

• objection: Can a screening test diagnose or rule out every cancer?
  response: Discuss test limitations, validation and appropriate follow-up with the veterinarian before ordering; do not treat a screen as a definitive diagnosis.
• objection: How much effort is involved in the blood draw and results?
  response: Canos describes mobile vet, own vet and group draw options, with report review alongside the vet.

competitors

• name: Volition
  why: Nu.Q Vet offers a canine cancer screening blood test through diagnostic partners.
• name: Antech Diagnostics
  why: Offers veterinary cancer diagnostics including Nu.Q screening.

keywords

• dog cancer blood test
• canine liquid biopsy
• dog cancer screening
• canine cancer recurrence monitoring
• dog genetic health test
• veterinary oncology diagnostics

voice

• reassuring and family-oriented
• scientific but accessible
• proactive about care

signals

• text: A dog has completed cancer treatment and its owner wants recurrence monitoring.
• text: A veterinary practice is expanding preventive screening or oncology services for older dogs.

pricing

motion

channels

• direct online ordering
• veterinary partnerships
• events

confidence

Founders

• name: Ming-shan Tsai
  title: Founder/CEO
  role: CEO
  bio: Founder/CEO at Canos. Previously co-founded and CSO of ZYTCA, built the best team in animal health, and launched multiple veterinary diagnostic products from 0 to 1, including an AI-driven digital pathology system distributed to 10,000+ vet clinics in China. Pivoted from business management to an Oxford biology PhD, from human health to animal health, and from infectious disease to cancer. I'm unstoppable when it comes to solving problems for animals. Our pets deserve the best tech.